CDEK
← All organizations

ALK-Abello, S.A.

For profitWebsite ↗

Also known as: ALK ABELLO | ALK-Abelló | ALK - Abello A/S | ALK-Abello A/S | ALK-Abelló A/S | ALK-Abelló A/S, Boege Alle 6-8, 2970 Hoersholm, Denmark | ALK-Abello, Inc. | ALK Nordic A/S, Danmark Filial | ALK-SCHERAX Arzneimittel GmbH | Allergy Laboratories, Inc. | Center Laboratories, Inc. | Clinical Research Director, ALK-Abelló, S.A.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Feb 1, 1996

First marketed drug

Jun 14, 1930

Last known activity

Sep 30, 2025

Timeline

1920s

  1. Jan 1, 1923

    ALK-Abello, S.A.— Founded

1930s

  1. Jul 11, 1930

    house dust mite allergen— NDA Secondary Org

2010s

  1. Apr 26, 2010

    Artu Biologicals— Acquired

  2. Feb 12, 2014

    Bio-Medical Services— Acquired

  3. Dec 10, 2015

    ciprofloxacin— Marketing Organization

Drugs by trial phase (39 distinct, 67 trials)

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (19)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Copenhagen, DK Jan 1, 1923
Last known activity
Sep 30, 2025